Back
Design Therapeutics 10K Form
Sell
39
DSGN
Design Therapeutics
Last Price:
3.64
Seasonality Move:
14.7%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive DSGN News And Ratings
See the #1 stock for the next 7 days that we like better than DSGN
DSGN Financial Statistics
Sales & Book Value
| Annual Sales: | $230K |
|---|---|
| Cash Flow: | $-12.83M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $4.92 |
| Price / Book: | 0.76 |
Profitability
| EPS (TTM): | -1.20000 |
|---|---|
| Net Income (TTM): | $-66.86M |
| Gross Margin: | -- |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Design Therapeutics Earnings Forecast
Key Design Therapeutics Financial Ratios
- Per Share Earnings over the last 5 years have been positive in 0 years.
Design Therapeutics Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | DSGN |
| Website: | designtx.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
DSGN Technical Analysis vs Fundamental Analysis
Sell
39
Design Therapeutics (DSGN)
is a Sell
Is Design Therapeutics a Buy or a Sell?
-
Design Therapeutics stock is rated a Sell
The current Design Therapeutics [DSGN] share price is $3.72. The Score for DSGN is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.